AU Patent

AU2013205442B2 — Crystalline forms of dimethoxy docetaxel and methods for preparing same

Assigned to Aventis Pharma SA · Expires 2016-05-12 · 10y expired

What this patent protects

Abstract Crystalline Forms of Dimethoxy Docetaxel and Methods for Preparing Same. The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2a-benz…

USPTO Abstract

Abstract Crystalline Forms of Dimethoxy Docetaxel and Methods for Preparing Same. The invention relates to anhydrides, solvates and ethanol hetero-solvates and hydrates of dimethoxy docetaxel or (2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenyl-propionate of 4-acetoxy-2a-benzoyloxy-5 ,20-epoxy-i -hydroxy-7p, 1 0p-dimethoxy-9-oxo-tax- 11 -ene 13a-yle, and to the preparation thereof.

Drugs covered by this patent

Patent Metadata

Patent number
AU2013205442B2
Jurisdiction
AU
Classification
—
Expires
2016-05-12
Drug substance claim
No
Drug product claim
No
Assignee
Aventis Pharma SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.